We are live on
!
Find out more
CCM
Cullen Capital Management Portfolio holdings
AUM
$9.75B
1-Year Est. Return
21.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.14%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$1.8B
AUM Growth
+$74.2M
(+4.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-7.38%
Top 10 Holdings %
Top 10 Hldgs %
28.04%
Holding
139
New
17
Increased
38
Reduced
62
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$48.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$4.42M |
| 3 |
Duke Energy
DUK
|
+$3.29M |
| 4 |
Broadcom
AVGO
|
+$3.08M |
| 5 |
ICICI Bank
IBN
|
+$2.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
+$52.2M |
| 2 |
Target
TGT
|
+$17.4M |
| 3 |
Cisco
CSCO
|
+$11.2M |
| 4 |
Novartis
NVS
|
+$10.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.63% |
| 2 | Healthcare | 15.26% |
| 3 | Consumer Staples | 13.23% |
| 4 | Industrials | 12.28% |
| 5 | Technology | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
JPMorgan Chase
JPM
$916B
| $60.7M | 3.37% |
477,305
-85,976
| -15% | -$9.61M |
|
2
Morgan Stanley
MS
$319B
| $55.6M | 3.09% |
811,400
-71,305
| -8% | -$4.09M |
|
|
3
Johnson & Johnson
JNJ
$640B
| $52.3M | 2.91% |
332,630
-69,290
| -17% | -$10.2M |
|
|
4
Novartis
NVS
$302B
| $49.6M | 2.75% |
525,026
-119,909
| -19% | -$10.5M |
|
|
5
Unilever
UL
$142B
| $49M | 2.72% |
+720,948
| New | +$48.9M |
|
6
Genuine Parts
GPC
$17.9B
| $48.3M | 2.69% |
481,424
-56,047
| -10% | -$5.48M |
|
7
RTX Corp
RTX
$290B
| $47.8M | 2.65% |
668,392
-114,906
| -15% | -$7.55M |
|
8
NextEra Energy
NEE
$184B
| $47.6M | 2.64% |
617,236
-118,344
| -16% | -$8.85M |
|
|
9
Target
TGT
$66.3B
| $47.3M | 2.63% |
267,785
-104,465
| -28% | -$17.4M |
|
10
Chubb
CB
$140B
| $46.8M | 2.6% |
304,008
-37,023
| -11% | -$5.19M |
|
11
Johnson Controls International
JCI
$85.1B
| $45.9M | 2.55% |
986,235
-46,528
| -5% | -$2.07M |
|
12
BCE
BCE
$20.8B
| $45.5M | 2.53% |
1,063,849
-75,366
| -7% | -$3.22M |
|
13
Philip Morris
PM
$309B
| $45M | 2.5% |
543,760
-108,295
| -17% | -$8.43M |
|
14
Medtronic
MDT
$112B
| $44M | 2.44% |
375,806
-7,909
| -2% | -$871K |
|
15
Pfizer
PFE
$143B
| $42.2M | 2.35% |
1,147,759
-82,359
| -7% | -$3.02M |
|
16
Chevron
CVX
$382B
| $39.2M | 2.18% |
464,015
-80,680
| -15% | -$6.53M |
|
17
AT&T
T
$164B
| $38.8M | 2.16% |
1,787,844
+3,304
| +0.2% | +$71.3K |
|
18
Merck
MRK
$322B
| $38.1M | 2.11% |
487,881
-93,947
| -16% | -$7.19M |
|
|
SI
19
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $38.1M | 2.11% |
530,315
| – | – |
|
20
Lowe's Companies
LOW
$121B
| $37.4M | 2.08% |
233,068
-541
| -0.2% | -$87.9K |
|
21
Intel
INTC
$413B
| $37.2M | 2.07% |
747,539
-36,803
| -5% | -$1.8M |
|
22
Kimberly-Clark
KMB
$37.6B
| $37.1M | 2.06% |
275,054
-22,603
| -8% | -$3.16M |
|
23
3M
MMM
$91.8B
| $35.8M | 1.99% |
245,186
-1,914
| -0.8% | -$272K |
|
24
Bank of America
BAC
$429B
| $35.2M | 1.96% |
1,162,425
-153,203
| -12% | -$4.11M |
|
25
Dow Inc
DOW
$22B
| $34.9M | 1.94% |
629,456
-450
| -0.1% | -$23.2K |
|
Similar funds
FCM
URS
MPI
HL
DCP
CIM
MF
HI
Cullen Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Cullen Capital Management held 139 positions worth $1.8B, up 4.3% from $1.73B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Cullen Capital Management withdrew a net $133M in Q4 2020, closing 5 positions and reducing 62 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Cullen Capital Management opened a new position in Unilever worth $49M.
- Cullen Capital Management's largest Q4 2020 buy was Unilever: 720,948 shares worth $49M.
- Cullen Capital Management added most to Bristol-Myers Squibb in Q4 2020, an estimated $4.42M increase.
- Cullen Capital Management's biggest Q4 2020 reduction was Target, cutting an estimated $17.4M.
- Cullen Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $52.2M.
- Cullen Capital Management's ten largest holdings make up 28% of its $1.8B portfolio in Q4 2020.
- Cullen Capital Management opened 17 new positions and closed 5 in Q4 2020.
- Cullen Capital Management's portfolio value rose 4.3% quarter-over-quarter to $1.8B.
Based on Cullen Capital Management's 13F filing for Q4 2020, filed 26 Jan 2021.